Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 891-900 Newer>

Managed Care October 2003	Effects of rising malpractice premiums said to be overstated Health plans worried that the malpractice crisis may begin to affect access to physicians for their members may breathe a bit more easily, though there is still some cause for concern.
Managed Care October 2003 John Carroll	Massachusetts City Attempts To Import Drugs From Canada The outgoing mayor of Springfield, Mass., is taking on the FDA over his plan to buy medications at a discount from Canada.
Knowledge@Wharton	Analyzing Brand-name and Generic Drug Costs in the U.S. and Eight Other Countries A new study comparing average prices for pharmaceuticals in nine countries -- the US, Canada, Chile, France, Germany, Italy, Japan, Mexico and the UK -- shows that average prices are highest in Japan, while prices in other countries are between 6% and 33% lower than prices in the US.
BusinessWeek November 10, 2003 Arlene Weintraub	Biotech Startups: Take Your Time Until products are close to approval, the public shouldn't share the risk
BusinessWeek November 3, 2003 Peter Coy	Why Your Premiums Are Still On The Rise Kaiser Family Foundation says private employer-sponsored health-insurance premiums rose 13.9% this year, the most since 1989.
BusinessWeek November 3, 2003 Diane Brady	Biotech: Teva's Next Triumph? The Israeli maker of generics wants a piece of the fast-growing bio-drug market.
Entrepreneur November 2003 Melody Lan	Golden Opportunity Giving new meaning to the term "senior care" -- a former occupational therapist for the elderly and her husband have found success in the home care field by focusing on hiring the best possible caregivers.
BusinessWeek October 27, 2003 Catherine Arnst	Attention Deficit: Not Just Kid Stuff Drugmakers are starting to target an overlooked group: Adults with ADHD.
BusinessWeek October 27, 2003 Michael Arndt	Is Viagra Vulnerable? Eli Lilly's Cialis lasts for 36 hours -- and a $100 million ad blitz will spread the word.
Wired November 2003 Richard Martin	It's Wake-Up Time Kiss your pillow good-bye. A new breed of drugs promises to do for drowsiness what Prozac did for depression.
<Older 891-900 Newer> Return to current articles.